Wenping Zhou
Overview
Explore the profile of Wenping Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
770
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou W, Zhang D, Yang M
Heliyon
. 2024 Dec;
10(23):e40761.
PMID: 39719990
Rain erosion induced by raindrops impacting wind turbine blades at high velocity can change the aerodynamic characteristics of the blades and increase maintenance costs. Previous numerical studies on rain erosion...
2.
Zhou W, Xu C, Niu J, Xiong Y, He Z, Xu H, et al.
Cell Signal
. 2024 Aug;
122:111346.
PMID: 39147296
Background: Eplerenone is a selective aldosterone receptor blocker that is effective in preventing the progression of chroinic kidney disease (CKD). However, its mechanism and role in CKD pregnancy still remain...
3.
Zhou W, Ghersi J, Ristori E, Semanchik N, Prendergast A, Zhang R, et al.
Development
. 2024 Aug;
151(17).
PMID: 39101673
The dorsal aorta (DA) is the first major blood vessel to develop in the embryonic cardiovascular system. Its formation is governed by a coordinated process involving the migration, specification, and...
4.
Zhao M, Zhang Y, Li L, Liu X, Zhou W, Wang C, et al.
Cancer Cell Int
. 2023 Oct;
23(1):244.
PMID: 37848941
Background: Primary hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality. KH domain-containing, RNA-binding signal transduction-associated protein 3 (KHDRBS3) is an RNA-binding protein that is aberrantly expressed in...
5.
Zhou W, Miao J, Cheng Z, Wang Z, Wang J, Guo H, et al.
Mol Ther Oncolytics
. 2023 Sep;
30:216-226.
PMID: 37663131
CD19-targeted chimeric antigen receptor-modified T (CD19 CAR-T) cell therapy has been demonstrated as one of the most promising therapeutic strategies for treating B cell malignancies. However, it has shown limited...
6.
Wang L, Wang X, Wu Y, Wang J, Zhou W, Wang J, et al.
Cancer Lett
. 2023 Jul;
568:216303.
PMID: 37422126
Chimeric antigen receptor T cell immunotherapy has achieved promising therapeutic effects in the treatment of hematological malignancies. However, there are still many obstacles, including on-target off-tumor antigen expression, that prevent...
7.
Zhou W, Li W, Wang S, Salovska B, Hu Z, Tao B, et al.
Nat Commun
. 2023 Jun;
14(1):3803.
PMID: 37365174
The serine/threonine kinase AKT is a central node in cell signaling. While aberrant AKT activation underlies the development of a variety of human diseases, how different patterns of AKT-dependent phosphorylation...
8.
Yan Z, Yao S, Wang Z, Zhou W, Yao Z, Liu Y
Front Immunol
. 2023 Feb;
14:1088685.
PMID: 36825002
Extranodal NK/T-cell lymphoma (ENKTCL) is the most common subtype of T/NK-cell lymphoma in Asia and Latin America, but very rare in North American and Europe. Patient survival has improved significantly...
9.
He Z, Zhang M, Xu H, Zhou W, Xu C, Wang Z, et al.
Pharm Biol
. 2022 Nov;
60(1):2308-2318.
PMID: 36428248
Context: Yiqi Huoxue Tongluo recipe (YHTR) is a traditional Chinese medicine for the treatment of chronic kidney disease, but its exact mechanism is not clear. Objectives: To monitor the potential...
10.
Yan Z, Yao Z, Wang H, Yao S, Wang X, Gao Y, et al.
J Clin Virol
. 2022 Oct;
157:105320.
PMID: 36240675
Background: Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related hematological malignancy. The presence of EBV-DNA in peripheral blood is a widely used ENKTCL tumor marker. However, there is no...